Azoospermia associated with a mutation in the ligand-binding domain of an androgen receptor displaying normal ligand binding, but defective trans- activation

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 12, 1998, Pages 4303-4309

  Wang, Qi ^a   Ghadessy, Farid J ^a   Trounson, Alan ^a,b   De Kretser, David ^a,b   McLachlan, Rob ^a,c   Ng, S C ^a   Yong, E L ^a,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b MONASH UNIVERSITY   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN BINDING PROTEIN; ANDROGEN RECEPTOR; FLUOXYMESTERONE; GLUTAMIC ACID; GLUTAMINE; MESTEROLONE; NANDROLONE; TESTOSTERONE;

AMINO ACID SUBSTITUTION; ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; AZOOSPERMIA; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DNA BINDING; GENE ACTIVATION; GENE MUTATION; GENETIC SCREENING; HORMONE RECEPTOR INTERACTION; HUMAN; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; POINT MUTATION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0032452556     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.12.4303     Document Type: Article

References (38)

1. 1. WHO. 1991 Infertility: a tabulation of available data on the prevalence of primary and secondary infertility. Geneva: WHO; 1-72.
2. 2. Schill WB. 1995 Survey of medical therapy in andrology. Int J Androl. 18(Suppl 2):56-62.
3. 3. Adamopoulos DA, Nicopoulou S, Kapolla N, Karamertzanis M, Andreou E. 1997 The combination of testosterone undecanoate with tamoxifen citrate enhances the effects of each agent given independently on seminal parameters in men with idiopathic oligozoospermia. Fertil Steril. 67:756-762.
4. 4. Abdelmassih R, Dhont M, Comhaire F. 1992 Pilot study with 120 mg andriol treatment for couples with a low fertilization rate during in-vitro fertilization. Hum Reprod. 7:267-268.
5. 5. Gerris J, Comhaire F, Hellemans P, Peeters K, Schoonjans F. 1991 Placebo-controlled trial of high-dose mesterolone treatment of idiopathic male infertility. Fertil Steril. 55:603-607.
6. 6. Perez-Pelaez M, Jeyendran RS. 1987 Effect of fluoxymesterone therapy on semen quality in the treatment of subfertile men. Arch Androl. 19:183-185.
7. 7. Urry RL, Cockett AT. 1976 Treating the subfertile male patient: improvement semen characteristics after low dose androgen therapy. J Urol. 116:54-55.
8. 8. Comhaire F, Schoonjans F, Abdelmassih R, et al. 1995 Does treatment with testosterone undecanoate improve the in-vitro fertilizing capacity of spermatozoa in patients with idiopathic testicular failure? Hum Reprod. 10:2600-2602.
9. 9. WHO. 1989 Mesterolone and idiopathic male infertility: a double blind study. World Health Organisation task force on the diagnosis and treatment of infertility. Int J Androl. 12:254-264.
10. 10. Aiman J, Griffin JE. 1982 The frequency of androgen receptor deficiency in infertile men. J Clin Endocrinol Metab. 54:725-732.
11. 11. Morrow AF, Gyorki S, Warne GL, et al. 1987 Variable androgen receptor levels in infertile men. J Clin Endocrinol Metab. 64:1115-1121.
12. 12. Lubahn DB, Brown TR, Simental JA, et al. 1989 Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci USA. 86:9534-9538.
13. 13. Quigley CA, De Bellis A, Marschke KB, El Awady MK, Wilson EM, French FS. 1995 Androgen receptor defects: Historical, clinical and molecular perspectives. Endocr Rev. 16:271-321.
14. 14. Lim J, Farid J Ghadessy, Yong EL. 1997 A novel splice site mutation in the androgen receptor gene results in exon skipping and a non-functional protein. Mol Cell Endocrinol. 131:205-2210.
15. 15. Yong EL, Tut TG, Ghadessy FJ, Prins G, Ratnam SS. 1998 Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain. Mol Cell Endocrinol. 137:41-50.
16. 16. Hiort O, Klauber G, Cendron M, et al. 1994 Molecular characterization of the androgen receptor gene in boys with hypospadias. Eur J Pediatr. 153:317-321.
17. 17. Tsukada T, Inoue M, Tachibana S, Nakai Y, Takebe H. 1994 An androgen receptor mutation causing androgen resistance in the undervirilised male syndrome. J Clin Endocrinol Metab. 79:1202-1207.
18. 18. Tut TG, Ghadessy F, Trifiro MA, Pinsky L, Yong EL. 1997 Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, defective sperm production and male infertility. J Clin Endocrinol Metab. 82 3777-3782.
19. 19. Grino PB, Griffin JE, Cushard WG, Wilson JD. 1988 A mutation of the androgen receptor associated with partial androgen resistance, familial gynaecomastia, and fertility. J Clin Endocrinol Metab. 66:754-761.
20. 20. McPhaul MJ, Marcelli M, Tilley WD, Griffin JE, Isidro-Gutierrez RF, Wilson J. 1991 Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high dose androgen therapy. J Clin Invest. 87:1413-1421.
21. 21. Weidemann W, Peters B, Romalo G, Spindler K-D, Schweikert H-U. 1998 Response to androgen treatment in a patient with partial androgen insensitivity and a mutation in the deoxyribonucleic acid-binding domain of the androgen receptor. J Clin Endocrinol Metab. 83:1173-1176.
22. 22. Yong EL, Chua KL, Yang M, Roy A, Ratnam SS. 1994 Complete androgen insensitivity due to a splice-site mutation in the androgen receptor gene and genetic screening with single stranded conformation polymorphism. Fertil Steril. 61:856-862.
23. 23. Jenster G, Spencer TE, Burcin MM, Tsai SY, Tsai MJ, O'Malley BW. 1997 Steroid receptor induction of gene transcription: a two-step model. Proc Natl Acad Sci USA. 94:7879-7884.
24. 24. Evans BAJ, Harper ME, Daniells CE, et al. 1996 Low incidence of androgen receptor mutations in human prostatic tumours using single strand conformation polymorphism analysis. Prostate. 28:162-171.
25. 25. Bevan CL, Brown BB, Davies HR, Evans BAJ, Hughes IA, Patterson MN. 1996 Functional analysis of six androgen receptor mutations identified in patients with partial androgen insensitivity syndrome. Hum Mol Genet. 5:265-273.
26. 26. Gottlieb B, Lehvaslaiho H, Beitel LK, Lumbroso R, Pinsky L, Trifiro M. 1998 The androgen receptor gene mutations database. Nucleic Acids Res. 26:234-238.
27. 27. De Bellis A, Quigley CA, Marschke KB, et al. 1994 Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome. J Clin Endocrinol Metab. 78:513-522.
28. 28. Laudet V, Hanni C, Coll J, Catzeflis F, Stehelin D. 1992 Evolution of the nuclear receptor gene superfamily. EMBO J. 11:1003-1013.
29. 29. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D. 1995 Crystal structure of the ligand binding domain of the human nuclear receptor RXR-α. Nature. 375:377-382.
30. 30. Renaud JP, Rochel N, Ruff M, et al. 1995 Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature. 378:681-689.
31. 31. Brzozowski AM, Pike AC, Dauter Z, et al. 1997 Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 389:753-758.
32. 32. Zirkin BR, Santulli R, Awoniyo CA, Ewing LL. 1989 Maintenance of advanced spermatogenic cells in the adult rat testis: quantitative relationship to testosterone concentration within the testis. Endocrinology. 124:3043-3049.
33. 33. Awoniyi CA, Santulli R, Chandrashekar V, Schanbacher BD, Zirkin BR. 1989 Quantitative restoration of advanced spermatogenic cells in adult male rats made azoospermic by active immunization against luteinizing hormone or gonadotropin-releasing hormone. Endocrinology. 125:1303-1309.
34. 34. Sun YT, Irby DC, Robertson DM, de Kretser DM. 1989 The effects of exogenously administered testosterone on spermatogenesis in intact and hypophysectomised rats. Endocrinology. 125:1000-1010.
35. 35. Sun YT, Wreford NG, Robertson DM, de Kretser DM. 1990 Quantitative cytological studies of spermatogenesis in intact and hypophysectomised rats: identification of androgen dependent stages. Endocrinology. 127:1215-1223.
36. 36. Yong EL, Wang Q, Tut TG, Ghadessy FJ, Ng SC. 1997 Male infertility and the androgen receptor: molecular, clinical and therapeutic aspects. Reprod Med Rev. 6:113-131.
37. 37. Comhaire F. 1990 Treatment of idiopathic testicular failure with high-dose testosterone undecanoate: a double-blind pilot study. Fertil Steril. 54:689-693.
38. 38. Yong EL, Ng SC, Roy AC, Yun G., Ratnam SS. 1994 Pregnancy after hormonal correction of severe spermatogenic defect due to mutation in androgen receptor gene. Lancet. 344:826-827.